A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Conditions
Breast Cancer · Metastatic Triple-Negative Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
BAPTIST ALLIANCE - MCI (Data Collection Only), Miami, Florida, United States
Emory University (Data Collection Only), Atlanta, Georgia, United States
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
Hackensack Meridian Health, Hackensack, New Jersey, United States
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States
Study leads
Sherry Shen, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center